10135-738 : Rifabutin 150 mg Oral Capsule
NDC: | 10135-738 |
Labeler: | Marlex Pharmaceuticals, Inc. |
Product Type: | Human Prescription Drug |
Drug Name: | Rifabutin |
Dosage Form: | Oral Capsule |
Application #: | ANDA215041 |
Rev. Date: |
NDC Package Codes:
- 10135-738-01: 100 CAPSULE IN 1 BOTTLE (10135‑738‑01)
Active Ingredients:
- Rifabutin
Dosage Strength:
- 150 mg
Pharmaceutical Classes:
- Rifamycin Antimycobacterial [EPC]
- Rifamycins [CS]
Related Products:
Based on records with the same trade name.- 59762-1350 Rifabutin 150 mg Oral Capsule by Greenstone LLC
- 60687-198 Rifabutin 150 mg Oral Capsule by American Health Packaging
- 68180-285 Rifabutin 150 mg Oral Capsule by Lupin Pharmaceuticals, Inc.
- 69189-0549 Rifabutin 150 mg Oral Capsule by Avera Mckennan Hospital
- 70954-041 Rifabutin 150 mg Oral Capsule by Novitium Pharma LLC
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 10135-737Next: 10135-739 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.